News

Upcoming Key Financial Releases from VILVI Group in 2025

Upcoming Key Financial Releases from VILVI Group in 2025

Upcoming Key Financial Releases from VILVI Group in 2025

The VILVI Group is gearing up for a series of key financial announcements in 2025. Understanding these releases can provide valuable insights for investors and stakeholders in the industry.

Monthly Sales Release

On the 10th day of each month, the VILVI Group will disclose consolidated sales figures from the previous month. These reports are essential as they showcase the company's performance trends and market response.

Interim Financial Statements

The first of the significant releases will occur on February 28, with the Interim Financial Statements for the full year of 2024. This document will cover the group’s overall financial health and performance over the year, providing a comprehensive overview that investors will find pivotal.

Audited Financial Statements

Following up, on April 8, 2025, VILVI Group will publish the audited financial statements for 2024. These statements are critical as they provide accuracy and credibility to the financial reports that shareholders rely upon to assess the company’s integrity.

Ordinary General Meeting of Shareholders

On April 29, the Ordinary General Meeting of Shareholders will be held. This meeting is an essential event for stakeholders to discuss the company's strategic direction, financial results, and future projections. It’s an opportunity for shareholders to voice their concerns and participate in the company’s governance.

Quarterly Financial Updates

The financial updates continue with another Interim Financial Statement for the first quarter of 2025 being released on May 30. This ongoing reporting ensures that investors remain current on the company’s performance.

Mid-Year Financial Statement

As the year progresses, the Interim Financial Statements for the six months ending August will be released on August 29. Monitoring these updates provides insights into the company’s performance halfway through the fiscal year, enabling stakeholders to make informed decisions.

Third Quarter Financial Overview

Finally, the Interim Financial Statements for the nine months of 2025 will follow on November 28. This report will be vital for stakeholders as it reflects the company's performance just before year-end, allowing for adjustments and strategic planning for the future.

Company Contact Information

For further inquiries, Vilija Milaseviciute, the Economics and Finance Director, can be contacted at +370 441 55 102 or via email at vilija.milaseviciute@vilvi.eu. Having direct contact is beneficial for those seeking detailed insights into VILVI Group's operations and financial outlook.

Frequently Asked Questions

What are the key financial releases from VILVI Group in 2025?

The key releases include monthly sales updates and interim financial statements throughout the year.

When is the Ordinary General Meeting of Shareholders?

The meeting is scheduled for April 29, 2025.

How often will VILVI Group release financial statements?

VILVI Group will provide financial statements every quarter as well as additional monthly sales reports.

Who can I contact for more information about VILVI Group?

You can reach out to Vilija Milaseviciute at +370 441 55 102 or by email at vilija.milaseviciute@vilvi.eu.

Why are these financial releases important?

They provide essential insights into the company's performance and help shareholders make informed investment decisions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

One Stop Swap eyes school fundraising for growth

Updated Category News Views 172

Transforming Fundraising with a Marketplace Twist Sometimes the real treasures are not tucked in textbooks but found in cluttered closets and basements. Enter One Stop Swap with a big idea—they're cooking up a fundraising strategy for schools that could shake things up by helping families sell their unused stuff. It's got that grassroots vibe with the potential to carve...

Continue Reading
Lectric Rolls Out Limited-Edition XP4 Ebike Upgrades

Updated Category News Views 51

Pedaling into a New Era of eBikes When the top contender in the American eBike world rolls out something new, you'd better believe it's worth a look. Lectric eBikes has just unwrapped three limited-edition versions of their beloved XP4, revealing a fresh take on a ride already admired by thousands. Let's dig into this new release. What's New with the XP4 This ain't just a...

Continue Reading
Florida Cancer Institute Expands: New Oncologist Joins Team

Updated Category News Views 0

News in the medical world isn't just rattling desks today; it's a purposeful signal for cancer care's transformation. Florida Cancer Specialists & Research Institute (FCS) has beefed up its team, embracing Carlos Barbur, DO, an oncologist who's not just skilled but steeped in disciplines crucial for the health of many. Think of this as another puzzle piece fitting snugly...

Continue Reading
MetaOptics Expands U.S. Reach with ADR Programme

Updated Category News Views 107

A Bold Move into the U.S. Market MetaOptics Ltd, the semiconductor optics dynamo out of Singapore, is kicking up some investment dust with their American Depositary Receipts (ADR) Programme aimed squarely at expanding its U.S. footprint. And let me tell you, in the game of international market expansion, that's no rookie maneuver. Why ADR? Why Now? So, why is MetaOptics...

Continue Reading
Target Hospitality Readies for Q3 2026 Earnings Reveal

Updated Category News Views 42

The Thrill of Earnings Season Every trader worth their salt gets a tingle down the spine come earnings season. There's nothing quite like it—the build-up, the anticipation, the potential payouts. This time, we're zeroing in on Target Hospitality, bearing the ticker NASDAQ: TH. Come November 9, 2026, they're set to unveil what the past quarter had up its sleeve, and like...

Continue Reading
Endeavor & GoPath's Game-Changing Cancer Test Launch

Updated Category News Views 0

Breaking Ground in Prostate Cancer Testing Just when you thought the medical field couldn't shake things up further, Endeavor Health and GoPath Diagnostics swoop in with a new genetic test for prostate cancer. This ain't just any run-of-the-mill test—it's the first of its kind to hit the clinical scene. The focus here is on sorting out which men with prostate cancer are...

Continue Reading
Nanchang Expo Showcases Future of Aviation and Space

Updated Category News Views 242

Aviation Dreams Take Off in Nanchang Not every day you see an expo spanning 30,000 square meters focused on aviation, especially where East meets innovation—Nanchang, the beating heart of Jiangxi Province, China, is where it's all happening this time around. October 31, 2026, saw the city launching not rockets but the 2026 Nanchang Aviation Industry Expo, and folks,...

Continue Reading
TAL's Festive Drinkware Hits Walmart for the Holidays

Updated Category News Views 0

Walmart's Shelves Get Festive with TAL's New Lineup Alright, so we've got TAL rolling out a limited-edition Holiday Coffee Collection exclusively at Walmart stores. You might wonder why a hydration brand is grabbing headlines right now, but listen up—this stuff just hit on November 2 and it's got the sparkle everyone's eyeing this season. What's Inside this Festive...

Continue Reading
Atrium's Heart Therapies: ATR 1072's Promising Data

Updated Category News Views 40

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

Continue Reading
Baystate Health Expands: A New Chapter with Mercy

Updated Category News Views 157

Baystate Health Moves Forward with Strategic Integration Well, here's a tale that's as much about legacy as it is about progress. Baystate Health has brought Baystate Mercy Hospital into its fold, blending history with future prospects. This integration, folks, isn't just a merger—it's a downright overhaul of how healthcare operates in Western Massachusetts. We’re...

Continue Reading

Top 5 Most Recently Viewed Articles

Twin Disc Offers Insight at Upcoming Growth Conference

Updated Category News Views 101

Twin Disc's Upcoming Presentation at a Key Conference Twin Disc, Inc. (NASDAQ: TWIN) is gearing up to make a notable appearance at the upcoming Noble Capital Markets Emerging Growth Equity Conference. The event will take place in Boca Raton and is set for a pivotal moment when Chief Financial Officer Jeff Knutson takes the stage to share insights into the company's future...

Continue Reading
Keymed Biosciences Achieves Milestone with Stapokibart Approval

Updated Category News Views 85

Keymed Biosciences Inc. Receives Approval for Stapokibart Keymed Biosciences Inc. (HKEX: 02162) has made impressive advancements in dermatological treatments with the recent marketing approval of Stapokibart. This innovative therapy targets moderate-to-severe atopic dermatitis in adults and has received endorsement from the National Medical Products Administration, the...

Continue Reading
Harnessing AI for Next-Level Value Creation in Tech Firms

Updated Category News Views 215

Harnessing AI for Next-Level Value Creation in Tech Firms In today's fast-paced technological landscape, the integration of artificial intelligence (AI) is reshaping the operational dynamics of companies. Innovators are exploring the potential of AI to redefine services, optimize processes, and create new avenues for revenue generation. In a notable address, an industry...

Continue Reading
CoinShares Reveals Successful Exercise of Share Options

Updated Category News Views 229

CoinShares Executes Employee Share Options with Success CoinShares International Limited (Nasdaq Stockholm Market: CS; US OTCQX: CNSRF) has made a significant announcement regarding its Employee Incentive Plan. Recently, the firm revealed that it has successfully exercised a total of 25,000 options from its Employee Incentive Plan - November 2020 Tranche. This is an...

Continue Reading
EverQuote's Impressive Q3 2025 Performance Highlights

Updated Category News Views 157

EverQuote Reports Strong Growth in Q3 2025 EverQuote, Inc. (Nasdaq: EVER), a prominent player in the online insurance marketplace, has revealed impressive financial results for the third quarter of 2025, showing significant growth across several critical metrics. Revenue surged by 20% year-over-year, reaching $173.9 million, reflecting the company's effective strategies...

Continue Reading